MEDNAX Inc.

Find Ratings Reports
MD : NYSE : Health Services
$57.51 -0.11 | -0.19%
Today's Range: 57.17 - 58.15
Avg. Daily Volume: 1098300.0
02/22/18 - 4:02 PM ET

Financial Analysis


MEDNAX INC's gross profit margin for the fourth quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. Sales and net income have grown, and although the growth in revenues has outpaced the average competitor within the industry, the net income growth has not.

During the same period, stockholders' equity ("net worth") has increased by 11.07% from the same quarter last year.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q4 FY17 Q4 FY16
Net Sales ($mil)910.82830.77
EBITDA ($mil)152.12168.03
EBIT ($mil)125.7142.78
Net Income ($mil)136.178.08


Balance Sheet Q4 FY17 Q4 FY16
Cash & Equiv. ($mil)70.4966.98
Total Assets ($mil)5867.285339.4
Total Debt ($mil)1852.821705.68
Equity ($mil)3066.452760.77


Profitability Q4 FY17 Q4 FY16
Gross Profit Margin28.6631.91
EBITDA Margin16.720.22
Operating Margin13.817.19
Sales Turnover0.590.6
Return on Assets5.466.08
Return on Equity10.4411.76
Debt Q4 FY17 Q4 FY16
Current Ratio0.01.31
Debt/Capital0.380.38
Interest Expense19.8416.36
Interest Coverage6.338.73


Share Data Q4 FY17 Q4 FY16
Shares outstanding (mil)93.5693.72
Div / share0.00.0
EPS1.460.84
Book value / share32.7829.46
Institutional Own % n/a n/a
Avg Daily Volume1196842.01420285.0

Valuation


HOLD. This stock's P/E ratio indicates a discount compared to an average of 20.01 for the Health Care Providers & Services industry and a discount compared to the S&P 500 average of 25.51. For additional comparison, its price-to-book ratio of 1.72 indicates a significant discount versus the S&P 500 average of 3.26 and a significant discount versus the industry average of 3.72. The price-to-sales ratio is well below the S&P 500 average, but well above the industry average. Upon assessment of these and other key valuation criteria, MEDNAX INC proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
MD 16.34 Peers 20.01   MD NA Peers 12.15

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

MD is trading at a discount to its peers.

 

Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.

Ratio not available.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
MD 12.64 Peers 16.04   MD 0.77 Peers 1.10

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

MD is trading at a discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

MD trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
MD 1.72 Peers 3.72   MD -1.43 Peers 46.07

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

MD is trading at a significant discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, MD is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
MD 1.53 Peers 0.94   MD 8.64 Peers 6.72

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

MD is trading at a significant premium to its industry.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

MD has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades